Get ahead of standard treatments for NTRK fusion-positive cancer. Participating in a clinical trial for NTRK fusion-positive cancer gives you access to the latest therapies.Call +1 844 627 7246
If your doctor has told you that your cancer is NTRK fusion positive, it means that an important gene has joined together, or fused, with another. The NTRK gene produces a protein that’s needed for healthy development and survival of nerve cells. (There are actually three versions of the gene, known as NTRK1, NTRK2, and NTRK3.) Like certain other genes, NTRK can, in rare cases, fuse with other genes. An NTRK gene fusion has been found to promote the spread of several forms of solid-tumor cancer. NTRK mutations, or DNA errors, may also occur in this gene, though less is known about this alteration.
Several drugs that target the NTRK gene fusion and slow the spread of cancer have become available in recent years. For patients who test positive for this genetic abnormality, clinical trials of NTRK inhibitors are another option.
A clinical trial is a research study in which scientists evaluate the effectiveness and safety of new medical treatments. That includes new drugs or novel combinations of drugs for treating cancer and other diseases. Every drug approved by the U.S. Food and Drug Administration had to be tested first in clinical trials.
We combine the power of technology with our dedicated team of medical providers to find you the best treatment options available.Access the free matching tool
Massive Bio offers a quick, easy, and FREE way to find clinical trials for patients like you. With our unique clinical trial matching system and compassionate team, Massive Bio can rapidly match you to clinical trials of new therapies. If you aren’t sure if your cancer is NTRK fusion positive, that’s okay. Additional testing can help determine your exact diagnosis.
“Massive Bio has gone above and beyond to connect my family with the right care during Covid-19. I really appreciate their staff’s consistent and clear outreach during this process.“
They have a really responsive and hard-working team. It’s a great way to explore clinical cancer trials and find alternative treatments.
I reached out to Massive Bio after learning of a recent breast cancer diagnosis of a family member. From free expert clinical trial matching to patient advocate support, Massive Bio was able to provide me with the necessary resources and knowledge to provide my family member the support they needed during their cancer journey.
My father used the Virtual Tumor Board to get another treatment recommendation. The report was detailed, and the staff answered all our questions. I definitely recommend their services.
I have recommended this to colleagues for patients that could benefit from clinical trials or have exhausted their treatment options and need a second opinion. Massive Bio’s team puts great minds together to find better solutions for patients that might think they have none left.
Massive Bio’s team is amazing. They work tirelessly to help patients and providers. This company truly cares about the work they are doing and the care they are delivering.
Talk to us. Our nurses and patient advocates are here and happy to help you. You are not alone in this fight.Call +1 844 627 7246
Clinical trials test the latest scientific advancements in HER2-Positive cancer treatment. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. HER2-Positive cancer patients can gain access to promising drugs and innovative treatments long before they're made available to the public.
At Massive Bio, our goal is to ensure that all cancer patients have access to clinical trials of innovative new treatments that offer hope for improved outcomes. Our unique SYNERGY-AI technology rapidly generates a personalized clinical trial matching report, which is FREE to patients and doctors.